Product

Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine

1 clinical trial

1 indication

Indication

Healthy Population

Clinical trial

A Single-center, Randomized, Blind, Positive Control Phase III Clinical Trial to Evaluate Immunogenicity and Safety of Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged From 6 Months to 5 Years

Status: Active (not recruiting), Estimated PCD: 2024-08-30